I have previously written on the topic of naturalising mystical states (see here, here, and here), arguing that the phenomenological character of these experiences can fit into a naturalistic worldview, that is, the view that only the natural world exists, or the view which rejects the existence of supernatural realms, forces, laws, principles, and entities.…
View Post
The combination of psychedelics and cannabis is a common one. The addition of cannabis to a psychedelic experience might be at any point, including before the dose is taken, before the peak, at the peak, after the peak, and during the comedown phase. Some might prefer to smoke at some point more than others (such…
View Post
Unlike many other substances, psychedelics can create a lingering feeling of well-being, long after the altered state of consciousness has subsided. This is known as an ‘afterglow’. Drugs like cocaine, amphetamine, methamphetamine, and (for many) MDMA are associated with ‘comedowns’. When the high fades after the use of these drugs, you may be left with…
View Post
‘Set’ – what you as an individual bring to a psychedelic experience – plays a significant role in how a specific trip will turn out. This one half of ‘set and setting’ (the latter encompassing environmental factors) is often framed as your mood and emotional state going into an experience. Do you feel positive and…
View Post
Dr Rick Strassman, currently an Adjunct Associate Professor of Psychiatry at the University of New Mexico, is one of the leading pioneers of modern psychedelic research. His studies on DMT, which took place between 1990 and 1995, broke the 20-year gap in psychedelic research. Strassman’s work on DMT, which kickstarted what has become known as…
View Post